<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Use of cell-free DNA for secondary screening in women at high risk of Down syndrome</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Use of cell-free DNA for secondary screening in women at high risk of Down syndrome</h1>
<div class="graphic"><div class="figure"><div class="ttl">Use of cell-free DNA for secondary screening in women at high risk of Down syndrome</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">The flowchart assumes the prevalence of Down syndrome (trisomy 21) is 1:100 in the high-risk population. In addition, the cfDNA detection rate for Down syndrome is 99.5%, the associated false-positive rate is 0.05%, and the overall test failure rate is 1%. Among the 12,000 high-risk singleton pregnancies, 120 will have Down syndrome, and for simplicity, the remaining population will be euploid (unaffected). Among the 120 Down syndrome pregnancies, 1 will be a test failure, 1 will be screen negative, and the remaining 118 will be screen positive. Among the 11,880 euploid pregnancies, 6 will be false positive, 11,755 will be screen negative, and 119 will have a test failure.<br/>The associated table shows a summary of those pregnancies that screen positive (118 TP and 6 FP or approximately 1% of the 12,000), screen negative (1 FN and 11,755 TN or approximately 98%), as well as those in which the test failed to provide a result (1 TP and 119 TN or approximately 1%). Women who were screen positive would be offered diagnostic testing and would, as a group, have a PPV of 95% (odds 20:1). Among those women who screen negative, no further testing for Down syndrome would be warranted (routine care) as their risk has been reduced to approximately 1:12,000. Among those women with a failed test, there would be several options as their residual risk of 1:119 is quite similar to their group risk of 1:100 prior to testing. The test could be repeated and the subsequent result used, or, since the woman was a high risk to begin with and her risk has not changed, the offer of diagnostic testing is reasonable.</div><div class="graphic_footnotes">cfDNA: cell-free DNA; PPV: positive predictive value; TP: true positive; FP: false positive; FN: false negative; TN: true negative.</div><div class="graphic_reference">Courtesy of Glenn E Palomaki, PhD, Geralyn M Messerlian, PhD, and Jacquelyn V Halliday, MS.</div><div id="graphicVersion">Graphic 103823 Version 5.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
